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Abstract
This paper presents the data from our own research of frequency of full regular trisomy 17 (T17) based on 1808 samples 
of miscarriages, 1572 medical induced abortions at 5–11 weeks of gestation, and 9689 samples of invasive prenatal tests done 
between 11 and 24 weeks of pregnancy. The frequency of full T17 in all miscarriages was 1/152 and in medical induced abor-
tions – 1/524; the population frequency of T17 in the first trimester accounted for 1/454.
Additionally, it presents the data on the proportion of T17 of all autosomal trisomies structure in different periods of fetal 
development. When performing invasive prenatal testing we detected 4 cases of T17 that represented 0,58 % of autosomal trisomies 
among fetuses of 11–22 gestational weeks.
Furthermore, the paper introduces a symptom-complex of fetal abnormalities that are typical of regular full trisomy 17.
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1. Introduction
Chromosomal abnormalities (CA), whose frequency makes up 50–60 % of early reproduc-
tive losses and due to the natural mortality rate goes down to 0.5–0.7 % of live births, holds a spe-
cific place in the structure of congenital and hereditary diseases. 
Trisomies constitute the largest proportion of all chromosomal abnormalities.
Over the past 40 years, or even more, there have been performed only a few large-scale stud-
ies in which the number of karyotype sample from missed abortions exceeded 1,000 specimen of 
non-developing products of concept [1–4]. While these studies were carried out at different times in 
different countries and populations, in all of them trisomy prevailed in the structure of chromosom-
al abnormalities found in missed pregnancies, with its portion varying from 44 to 66 % (Table 1).
Table 1
The study of first trimester miscarriages karyotypes
Boue 
1975
Hassold 
1980
Kline 
1987
Menasha 
2005
Total analyzed 1498 1000 2098 1203
Total anomalies 921 (61,5 %) 463 (46,3 %) 776 (37,6 %) 792 (65,8 %)
Trisomy 479 (52,0 %) 207 (44,5 %) 368 (47,4 %) 522 (65,9 %)
The analysis has shown unequal participation of different chromosomes in the structure 
of autosomal trisomies. Trisomies 21, 18 and 13 in newborn infants generally account for 95 % of 
chromosomal abnormalities. In the earlier stages of fetal development, this rate is lower. Therefore 
it is assumed that all trisomies, except 21, 18, and 13, are rare.
Rare trisomies should be a key focus, since phenotype of fetuses with such abnormalities is 
not yet described for their low frequency. Until now it has been believed that trisomy 1 and trisomy 
19 are incompatible with postimplantation development [5].
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Our research experience over the last 20 years proves that there is a whole spectrum of au-
tosomal trisomies (including such rare ones as regular trisomies 1 and 19) in the structure of early 
reproductive losses of first trimester.
The analysis of frequency of rare trisomies detected in the process of prenatal diagnosis at 
11–26 weeks (early and middle periods of fetal development) has shown a large proportion of T8, 
T9, T22, T14, T16, T20, T17 and T15 in the structure of prenatally diagnosed abnormalities, but of 
all those mentioned only T8, T9, T22 have been classified into separate syndromes [6].
Special mention in this context should be made of the cases of full regular trisomy 17. In 
known reputable sources, directories, guides, manuals, and electronic databases (PubMed, Med-
line, OMIM) we have not found any description of phenotype for fetus with regular trisomy 17 
(only cases of mosaic trisomies 17 are specified) [7, 8].
2. Aim of research
To determine the frequency and mortality of regular trisomy 17 based on the cases we were 
fixing through our multi-year research, and to describe a symptom- complex of fetal abnormalities 
that are typical for regular full trisomy 17.
3. Materials and Methods
To meet our targets for the period of 1997 through 2016, we formed groups and made 
karyotyping of 1808 samples of miscarriages concept products, randomized group of 1572 med-
ical induced abortions at 5–11 weeks of gestation; 9689 samples of invasive prenatal tests done 
between 11 and 24 weeks of pregnancy (1329 chorionic villus biopsies, 2240 placental biopsies, 
and 6120 samples of amniotic fluid) - total 13069 samples from women inhabiting south-east and 
central regions of Ukraine. 
Prenatal ultrasound examinations were performed in the 1-st trimester pregnancy to identi-
fy the missed miscarriage, as well as in the periods of 11–14 weeks and 18–22 weeks of gestation 
with ultrasound systems HDI-3000 “ATL/Philps” (USA) and Voluson 730-Pro “General Electric” 
(USA). Prenatal invasive procedures were controlled using ultrasound scanners SSA-250 “Toshi-
ba” (Japan) and R-3 “Samsung-Medison” (Korea). After elimination of abnormal fetuses with chro-
mosomal aneuploidy, autopsy of abortus was done.
For the analysis we applied GTG (method for differential staining), and we used research 
microscopes Axioіmager A1 “Zeiss”, “Olimpus” BX41, Aristoplan “Leitz” to analyze chromosome 
spreads . Notice also that we met testing standard for chromosome spreads [9], evaluating no less 
than 30 metaphase plates.
4. Results
We have found that the proportion of T21, 18, and 13 in pre-embryonic period generally 
accounts for only 6.33 %, while that of rare trisomy – 93.67 %. Among pregnancies terminated in 
embryonic period of 5 to 11 weeks, the proportion of rare autosomal trisomies made up 88.2 %. In 
early fetal period of 11–14 gestational weeks, the rare autosome trisomies amounted to only 6.9 %; 
at 15–22 weeks – 3.83 %; after 23 weeks – 6.68 % (i. e., the average proportion of rare autosomal 
trisomies in the fetal group of early, middle and late period made 5.8 %).
The frequency of full T17 in all miscarriages was 1/152 and in medical induced abor-
tions – 1/524; the population frequency of T17 in the first trimester accounted for 1/454. In the 
process of study we have found that the proportion of trisomy 17 in autosomal trisomy structure 
varies in different periods of fetal development (Table 2).
 Specifically, in the group of first trimester miscarriages, T17 proportion averaged 1. 17 %. 
There were recorded 6 cases of full regular T17 (1 of anembryonic gestation and 5 with embryos 
which stopped growing), and 2 cases of mosaic T17 combined with polyploidy (one of them with 
double T17, karyotype: 94, XXXX, +17+17/47, XX+17 mos, the second one – with karyotype: 70, 
XXX+17/ 47, XX+17 mos) both of anembryonic gestation. In all these cases, pregnancy stopped 
developing at 5–9 weeks. When performing prenatal testing, we revealed 4 cases of trisomy 17 
(Table 3) that represented 0.58 % of autosomal trisomies among fetus of 11–22 gestational weeks.
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Table 2
Proportion of Т17 in structure of autosomal trisomies in different periods of fetal development
Chromosomal 
abnormality
Miscarriages  
Pre-embryonic stage 
(prior 5 weeks)
Miscarriages  
5–11 wks
Prenatal  
diagnostic 11–14 wks 
Prenatal  
diagnostic 15–22 wks
Trisomy +17 1 (0,79 %) 5 (1,53 %) 1 (0,43 %) 3 (0,72 %)
Table 3
Features of pregnancy with prenatally detected trisomy 17
№ Maternal age Gestational age (wks) Ultrasound findings Karyotype
1 23 22
Prenatal hypoplasia, ventricular septal defect, 
‘lemon’-shaped head, omphalocele, flexor position 
of hand, ‘rocker-bottom’ foot, umbilical cord cyst 
(Fig. 1, a, b)
47,XX+17
2 17 19-20 Prenatal hypoplasia,  nasal bone hypoplasia, brachycephaly. 47,XY+17
3 24 11 Exencephaly,omphalocele,spine deformation and shortening, feet deformation (Fig. 2) 47,XY+17 (Fig. 3)
4 24 20
Prenatal hypoplasia, severe hydrocephalus, facial 
dismorphism, nasal bone hypoplasia, complicated 
cardiac defect, abnormal limbs length (bilateral 
talipomanus, radial bone aplasia, flexion deformi-
ty of hand, unilateral abnormality of lower limb, 
fibula bone aplasia) spine deformity, small-sized 
omphalocele (Fig. 4, a–e)
47,XY+17
   
                                а                                                                                             b
Fig. 1. Echograms of fetus with the full trisomy 17 at 22 weeks of gestation:  
a − Transaxial section through the fetal thorax and heart (four-chamber view), ventricular  
septal defect; b − Transaxial section through the fetal abdomen; anterior wall defect: omphalocele
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In one case (№ 3) a fetus had severe malformations (Fig. 2), similar to ADAM-complex (se-
quence of amniotic bands), but meticulous ultrasound screening did not detect any manifestations of 
amniotic bands. Given these abnormalities, there were performed a prenatal differential diagnosis 
for thoracoabdominal syndrome, OEIS-complex (omphalocele-extrophy-imperforate anus − spinal 
defects), and with less potential trisomies of chromosomes 18 and 13 that necessitated the prenatal 
karyotyping which revealed the trisomy 17 (Fig. 3).
Fig. 2. 3D echography surface reconstruction of the fetus with the full trisomy 17 at 11 weeks 
of gestation. Multiple congenital anomalies: exencephaly, omphalocele, spine shortening and 
deformation, feet deformation
 Fig. 3. Karyogram of the fetus at 11 weeks of gestation in Chorionic villus sampling material:  
47, XY + 17 (10X100 increase; software “Video Test Karyo 3.1”)
In one case (№ 4) the prenatal differential diagnosis was made with TAR syndrome, which 
had been excluded, because the fetus had no manifestations of anemia. In addition to fetal abnor-
malities detected by ultrasound (Fig. 4, a−e) and later confirmed by autopsy (Fig. 5, a, b), there 
have been also found such dysmorphic disorder of face as hypertelorism, horizontal eye slits, wide 
and deep nasal bridge, and mild retromicrognathia.
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e
Fig. 4. Echograms of fetus with the full trisomy 17 at 20 weeks of gestation:  
a − transaxial section through the fetal head: hydrocephaly, choroid plexus hypoplasy and cysts;  
b − Transaxial section through the fetal thorax and heart. Abnormal four-chamber view: 
horisontal cardiac axis,complete atrio-ventricular channel; c − sagittal section of the fetal face: 
high forehead,deep nasal bridge, nasal bone hypoplasia, mild microretrognathy;  
d − sagittal section through the fetal upper limb: radiation clubhand, due to radial bone aplasy;  
e − transverse section of the deformed foot
      
 
 
       
 
 
 
 
                                a                                                                                            b
                                c                                                                                            d
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                                   a                                                              b
Fig. 5. Aborted fetus with the full trisomy 17 at 21 weeks of gestation.  
(Phenotype description in the text): a − front view; b − side view
Based on ultrasound and postmortem examinations, we have formed a symptom-complex of 
abnormalities which are typical of full regular trisomy 17 (Table 4).
Table 4
Symptom-complex of abnormalities which are typical of full regular trisomy 17
Anatomo-morphological structures Anomalies/features
Shape of the head Brachycephalic (1) ‘Lemon’ (1)
 Central nervous system
Exencephaly (1) 
Hydrocephalus (1)
Cerebellum hypoplasy (1)
Facial dismorphism
Hyperthelorism (1)
horizontal eye slits (1)
wide nasal bridge (1)
nasal bone hypoplasia (2)
retromicrognathy (1)
Heart Atrio-ventricular channel (1)Ventricular septal defects (1)
Anterior abdominal wall Omphalocele (3)
Spinal column Shortening and deformity (1)
Limbs − tubular bones Bilateral aplasia of the radial bones (1) &unilateral fibula aplasia (1) 
Hands and feet Flexion deformity (2/3)
Fetal growth (bioparameters) Prenatal hypoplasia: retardation  from gestational age (3)
Umbilical cord Cyst (1)
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As can be seen from the nature of the anomalies we have specified in the recorded cases, 
complete trisomy 17 is characterized by multiple non-inducing each other development abnormal-
ities in the different anatomo-morphological systems which are derived from ectoderm and meso-
derm, that allows us to regard the described symptom-complex as a syndrome.
5. Discussion
Full regular T17 fall within lethal AD and have never been observed among born-alive 
infants, that is also agrees with Hsu L. Y’s findings on T17 being found only among spontaneous 
abortions with 0.1 %-frequency [10].
Worldwide scientific literature points to descriptions of only 29 prenatally diagnosed cas-
es of mosaic T17, of which only 9 (31.03 %) had abnormal ultrasound findings correlated with a 
high percentage of mosaic trisomic clones in cell culture of amniotic fluid that ranged from 23 % 
to over 50 % [8].
All these cases had adverse pregnancy outcomes and included the following ultrasound 
findings: fetal growth delay (prenatal hypoplasia), cerebellar hypoplasia and/or cerebellar verm-
ian hypoplasia, ventriculomegaly, nuchal cystic hygroma, nuchal thickening, congenital heart dis-
ease (ventricular septal defect), pleural effusions (hydrothorax), vertebral anomaly, abnormal limb 
length, foot deformity, and single umbilical artery. Among postnatal findings, in most cases, there 
were also described hypoplasia of cerebellum, facial dismorphism, ventricular septal defect, body 
asymmetry and tibial length differences, in two cases – inguinal hernia and postaxial polydactyly, 
by one case of kyphoscoliosis, duodenal atresia, intestinal malrotation, cardiomyopathy, ventricu-
lomegaly and hydrocephalus. Further, in some cases were recorded neuropsychiatric development, 
peripheral neuropathy, hearing and vision loss, and growth delay. Life expectancy of children with 
mosaic trisomy 17 ranged from 9 days to 9 years. Baltensperger A. produced a summary of pre- 
and postnatally described all phenotypic signs and symptoms of mosaic T17 with some additional 
features from their own observation over this chromosome [7]. According to these and other au-
thors [7, 8], big differences in phenotypic features of fetus and infants with mosaic T17 should be 
explained by different percentage of mosaic abnormal cell clones, their different presence in a va-
riety of anatomical and morphological tissue and moderate-sized sample of observations. As noted 
above, in most cases of mosaic T17 described in various sources, there were no anomalies both in 
pre- and postnatal period, and they all ended with a natural birth [8].
In such cases, to confirm mosaic T17, complementary to chromosomal analysis of amniotic 
fluid cultures, there was performed a cytogenetic analysis of blood lymphocytes and fibroblasts of 
neonates that recognized as ‘gold’ standard, [7]. However, the level of mosaicism varies greatly 
in different tissues and does not correlate with prognosis [11–20]. Molecular genetic analysis has 
confirmed mosaic T17 in several cases resulted from postzygotic mitotic errors in distribution of 
maternal chromosome 17 [13, 16, 18]. Parental origin of extra chromosome 17 was determined with 
genome-wide SNP-microarray molecular genetic analysis [11].
The phenotypic portrait of fetuses with full regular T17 that we described also included 
prenatal hypoplasia, hypoplasia of cerebellum, facial dysmorphism, hydrocephalus, heart septal 
defect, abnormal spine, asymmetric abnormalities of long bones, and foot deformities. But the 
distinctive feature of symptom-complex of full T17 in our description is the presence of omphalo-
cele in 3 of 4 fetuses and umbilical cord cyst in one of them. Thus, the detected signs allowed us to 
describe a phenotypic portrait of previously undescribed syndrome of full trisomy 17.
6. Conclusions
1. Frequency of full trisomy 17 in all miscarriages was 1/152 and in medical induced abor-
tions − 1/524; the population frequency of T17 in the first trimester accounted for 1/454.
2. Trisomy 17 represented 1,17 % of all autosomal trisomies among embryos at 5−11 gesta-
tional weeks and 0,58 % only of autosomal trisomies among fetuses of 11−22 gestational weeks.
3. The symptom-complex of regular full trisomy 17 second trimester fetuses includes cen-
tral nervous system anomalies, facial dismorphism, cardiac septal defects, omphalocele, limbs 
anomalies, prenatal hypoplasia, and asymmetry.
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